Naver Cloud became the first South Korean cloud service provider to develop a gene data analysis platform.
The newly-developed Nvidia Clara Parabricks on the platform of Naver Cloud, an affiliate of South Korea’s leading internet portal operator Naver Corp., is the combination of the Naver Cloud server with US graphics chip giant Nvidia Corp.’s Clara Parabricks software suite.
Clara Parabricks is a system that uses huge graphic processing units to interpret gene data.
Naver Cloud plans to launch the Genome Analysis All-in-One Integrated Platform in its marketplace in the first half of this year, in conjunction with local personal genomics business ichrogene.
Beginning with the cooperation with Nvidia and ichrogene, Naver Cloud will continue to expand its presence in the gene analysis market, according to the company’s executive director, Han Sang-young.


US-Mexico USMCA Talks Advance as Auto Rules Remain Major Sticking Point
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
Nasdaq Drops as AI Earnings, Oil Surge and Middle East Tensions Weigh on Wall Street
Super Micro Computer Stock Jumps 20% After Record AI Orders and Margin Surge
OpenAI Australia Data Center Switches Cooling Strategy After Recycled Water Plan Fails
Gold Price Holds Above $4,130 as Fed Rate Outlook and Middle East Tensions Support Safe-Haven Demand
GE Vernova Q2 Revenue Tops Estimates as Earnings Miss, Shares Slide Despite Higher 2026 Outlook
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Canada Vows Trade Fight as Trump Imposes 50% Tariffs
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Trump Administration Monitors OpenAI Incident as Lawmakers Push AI Kill Switch Bill
Rubio Rejects AI ‘Kill Switch’ Claims as U.S. Defends American Technology Abroad
Uber Stock Falls as Waymo Plans to End Robotaxi Partnership by 2028
Gold Price Holds Above $4,000 as Fed Rate Hike Bets Rise on Oil-Driven Inflation
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
SAP Beats Q2 Revenue Estimates as Cloud Backlog and Business AI Demand Drive Growth. 



